SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company's senior executives and directors who signed the Registration Statement, effective February 7, 2024,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Robbins LLP Reminds Kyverna Therapeutics, Inc. Investors of the Pending Securities Fraud Class Action Against KYTX )
Also on site :
- Oil prices up after reports of 3 ships on fire in Gulf of Oman near the strait of Hormuz
- Ron Taylor Passes Away
- Padres Select Bryce Johnson